Products 192564-14-0

CAS 192564-14-0 appears in our catalog under these names: Oritavancin diphosphate, 95%, Oritavancin Diphosphate, Oritavancin Phosphate, >95% (HPLC), Oritavancin, >95% (HPLC), Oritavancin diphosphate/ 100%. Offered by: Combi-blocks, Chemat Brand, TRC, TargetMol, GLPBio. Available pack sizes: 100mg, on request, 1mg, 25mg, 5mg, 2mg, 10mg, 50mg.

Oritavancin diphosphate, 95%
Combi-blocks
  • size: 100mg
  • Variants: 1
View product
Oritavancin Diphosphate
Chemat Brand, Biosynth
  • size: on request, 0,1g, 0,25g, 0,5g
  • Variants: 6
View product
Oritavancin Phosphate, >95% (HPLC)
TRC
  • size: 1mg, 5mg
  • Variants: 2
View product
Oritavancin, >95% (HPLC)
TRC
  • size: 25mg
  • Variants: 1
View product
Oritavancin diphosphate/ 100%
TargetMol
  • size: 2mg, 5mg, 10mg, 25mg
  • Variants: 7
from 445.96
View product
Oritavancin (phosphate)
GLPBio
  • size: 10mg, 100mg, 2mg, 5mg
  • Variants: 6
from 629.80
View product
Oritavancin diphosphate, 80%, 80%
Chemat
  • size: 2mg, 1mg, 5mg, 10mg
  • Variants: 7
from 338.00
View product
Oritavancin (diphosphate), 99.93%
MedChemExpress
  • size: 50 mg, 2 mg, 100 mg, 10 mg
  • Variants: 6
from 361.49
View product
Oritavancin (diphosphate) (Standard)
MedChemExpress
  • size: 100 mg, 5 mg, 50 mg, 2 mg
  • Variants: 6
from 839.82
View product
Oritavancin diphosphate, 80%
Fluorochem
  • size: 100mg
  • Variants: 1
from 7713.97
View product
Structural formula: {0} (CAS {1})

Oritavancin bisphosphate is a phosphate salt obtained by combining oritavancin with two molar equivalents of phosphoric acid. Used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms. It has a role as an antibacterial drug. It contains an oritavancin.

Source: ChEBI

Identity
Molecular formulaC86H103Cl3N10O34P2
Molecular weight1989.1 g/mol
IUPAC name(1S,2R,18R,19R,22S,25R,28R,40S)-2-[(2R,4S,5R,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5R,6S)-4-[[4-(4-chlorophenyl)phenyl]methylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-18,32,35,37-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid;phosphoric acid
InChIKeyPWTROOMOPLCZHB-BHYQHFGMSA-N
SMILESC[C@H]1[C@@H]([C@@](C[C@@H](O1)O[C@H]2[C@H]3C(=O)N[C@@H](C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)[C@H](C(=O)N3)NC(=O)[C@H]6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O[C@H]1C[C@]([C@H]([C@@H](O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)[C@H]([C@H](C(=O)N[C@H](C(=O)N6)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O.OP(=O)(O)O.OP(=O)(O)O

Computed by PubChem (NCBI)

Synonyms: Oritavancin diphosphate, oritavancin phosphate, Nuvocid, Kimyrsa, oritavancin bisphosphate, ORITAVANCIN PHOSPHATE (MART.), ORITAVANCIN PHOSPHATE [MART.], Orbactiv, Oritavancin diphosphate [USAN], Oritavancin (diphosphate)